
浏览全部资源
扫码关注微信
400042 重庆,陆军特色医学中心眼科
[刘莛,E-mail:tingliu1597@126.comLIU Ting, E-mail: tingliu1597@126.com
收稿:2022-02-26,
修回:2022-03-01,
纸质出版:2022-04-30
移动端阅览
孙煜林, 刘莛. 急性高眼压致大鼠视网膜节细胞焦亡及抗Caspase-1处理的神经保护作用[J]. 陆军军医大学学报, 2022,44(8):789-796.
Yulin SUN, Ting LIU. Acute ocular hypertension induced pyropotosis in rat retinal ganglion cells and protective effect of inhibiting Caspase-1 in rat model[J]. Journal of Army Medical University, 2022, 44(8): 789-796.
孙煜林, 刘莛. 急性高眼压致大鼠视网膜节细胞焦亡及抗Caspase-1处理的神经保护作用[J]. 陆军军医大学学报, 2022,44(8):789-796. DOI: 10.16016/j.2097-0927.202202158.
Yulin SUN, Ting LIU. Acute ocular hypertension induced pyropotosis in rat retinal ganglion cells and protective effect of inhibiting Caspase-1 in rat model[J]. Journal of Army Medical University, 2022, 44(8): 789-796. DOI: 10.16016/j.2097-0927.202202158.
目的
2
探讨在SD大鼠急性高眼压模型中,细胞焦亡及抗Caspase-1处理对视网膜神经节细胞(retinal ganglion cell,RGCs)的保护作用。
方法
2
42只SPF级雄性SD大鼠采用随机数字表法分为正常对照组、急性高眼压模型组和VX-765(Caspase-1抑制剂)干预组,均以右眼为实验眼。模型组和干预组用生理盐水前房灌法建立急性高眼压模型,干预组在建模当日及次日玻璃体腔注入VX-765(200 μmol/L)溶液4 μL,模型组于相同时间玻璃体腔注入等容量生理盐水。正常对照组不处理。造模后7 d处死大鼠,HE染色观察视网膜形态学变化及RGCs密度;免疫组化观察RGCs并检测视网膜平均光密度;实时荧光定量PCR检测视网膜Caspase-1、gsdmd、IL-1b、IL-18分子mRNA表达;Western blot法检测Caspase1-p20、gsdmd-n、IL-1b、IL-18蛋白表达。
结果
2
模型组大鼠视网膜厚度为(164.53±1.04)μm,低于正常对照组和干预组,模型组RGCs密度为(332.87±16.37)个/mm
2
,低于正常对照组和干预组,模型组大鼠视网膜光密度为(0.443±0.014),低于正常对照组(0.517±0.015)和干预组(0.492±0.006),差异均有统计学意义(
P
<
0.05)。模型组大鼠视网膜IL-1b、IL-18 mRNA相对表达量高于正常对照组和干预组,Caspase 1-p20、gsdmd-n、IL-1b、IL-18蛋白相对表达量同样高于正常对照组和干预组,差异均有统计学意义(
P
<
0.05)。
结论
2
急性高眼压暴露后,依赖Caspase-1的细胞焦亡通路分子表达明显增多,抑制Caspase-1活性能减轻视网膜组织损伤,有效保护RGCs,减少RGCs死亡数量。
Objective
2
To investigate the protective effect of pyroptosis and anti-Caspase-1 treatment on retinal ganglion cells (RGCs) in rats with acute ocular hypertension.
Methods
2
Forty-two SPF male SD rats were randomly divided into normal control group
acute ocular hypertension model group and VX-765 (Caspase-1 inhibitor) intervention group
with the right eye as the experimental eye. Acute ocular hypertension was inflicted by anterior chamber irrigation with normal saline in the model group and intervention group. The rats in the intervention group were further given 4 μL VX-765 (200 μmol/L) solution by intravitreal injection on the modeling day and the next day
and those of the model group were injected with equal volume of normal saline in vitreous cavity at the same time. No such treatment was performed on the rats from the control group. All rats were killed at the seventh day after modeling. Retinal morphology and the density of RGCs were observed by HE staining. The survival of RGCs and average absorbance of retina were observed by immunohistochemical assay. The mRNA levels of Caspase-1
gsdmd
IL-1b and IL-18 were detected by real-time fluorescence quantitative PCR. The protein expression of Caspase 1-p20
gsdmd-n
IL-1b and IL-18 were detected by Western blotting.
Results
2
The retinal thickness was 164.53±1.04 μm in the model group
which was significantly thinner than that in the normal control group (181.44±5.13 μm) and the intervention group (173.15±2.15 μm). The density of RGCs was (332.87±16.37)/mm
2
in the model group
obviously lower than that in the normal control group and the intervention group. The average absorbance of retina was 0.443±0.014 in the model group
statistically lower than in the normal control group (0.517±0.015) and the intervention group (0.492±0.006). The differences were statistically significant in above values (
P
<
0.05). The mRNA relative expression levels of IL-1b and IL-18 were significantly higher in the model group than the control group and intervention group (
P
<
0.05). The protein levels of Caspase1-p20
gsdmd-n
IL-1b and IL-18 were remarkably higher in the model group than the other 2 groups (
P
<
0.05).
Conclusion
2
Acute ocular hypertendion exposure enhances the expression of the molecules in Caspase-1-dependent pyropotosis pathway. So
inhibiting Caspase-1 activity can reduce the severity of retinal injury
protect RGCs effectively
and reduce RGCs death.
TANNER L, GAZZARD G, NOLAN W P, et al . Has the EAGLE landed for the use of clear lens extraction in angle-closure glaucoma? And how should primary angle-closure suspects be treated?[J ] . Eye (Lond), 2020, 34(1): 40-50. DOI: 10.1038/s41433-019-0634-5.
THAM Y C, LI X, WONG T Y, et al . Global prevalence of glaucoma and projections of glaucoma burden through 2040[J ] . Ophthalmology, 2014, 121(11): 2081-2090. DOI: 10.1016/j.ophtha.2014.05.013.
ZHU X L, ZENG W, WU S Y, et al . Measurement of retinal changes in primary acute angle closure glaucoma under different durations of symptoms[J ] . J Ophthalmol, 2019, 2019: 5409837. DOI: 10.1155/2019/5409837.
WEINREB R N, AUNG T, MEDEIROS F A. The pathophysiology and treatment of glaucoma: a review[J]. JAMA, 2014, 311(18): 1901-1911. DOI: 10.1001/jama.2014.3192.
MORRISON J C, NYLANDER K B, LAUER A K, et al . Glaucoma drops control intraocular pressure and protect optic nerves in a rat model of glaucoma[J ] . Invest Ophthalmol Vis Sci, 1998, 39(3): 526-531.
ALMASIEH M, WILSON A M, MORQUETTE B, et al . The molecular basis of retinal ganglion cell death in glaucoma[J ] . Prog Retin Eye Res, 2012, 31(2): 152-181. DOI: 10.1016/j.preteyeres.2011.11.002.
BAR1Ş M, TEZEL G. Immunomodulation as a neuroprotective strategy for glaucoma treatment[J]. Curr Ophthalmol Rep, 2019, 7(2): 160-169. DOI: 10.1007/s40135-019-00212-1.
BAUDOUIN C, KOLKO M, MELIK-PARSADANIANTZ S, et al . Inflammation in glaucoma: from the back to the front of the eye, and beyond[J ] . Prog Retin Eye Res, 2021, 83: 100916. DOI: 10.1016/j.preteyeres.2020.100916.
WILLIAMS P A, MARSH-ARMSTRONG N, HOWELL G R, et al . Neuroinflammation in glaucoma: a new opportunity[J ] . Exp Eye Res, 2017, 157: 20-27. DOI: 10.1016/j.exer.2017.02.014.
SILVERMAN S M, KIM B J, HOWELL G R, et al . C1q propagates microglial activation and neurodegeneration in the visual axis following retinal ischemia/reperfusion injury[J ] . Mol Neurodegener, 2016, 11: 24. DOI: 10.1186/s13024-016-0089-0.
JO D H, YUN J H, CHO C S, et al . Interaction between microglia and retinal pigment epithelial cells determines the integrity of outer blood-retinal barrier in diabetic retinopathy[J ] . Glia, 2019, 67(2): 321-331. DOI: 10.1002/glia.23542.
GONG Y R, CAO X N, GONG L, et al . Sulforaphane alleviates retinal ganglion cell death and inflammation bysuppress ing NLRP3 inflammasome activation in a rat model of retinal ischemia/reperfusion injury[J ] . Int J Immunopathol Pharmacol, 2019, 33: 2058738419861777. DOI: 10.1177/2058738419861777.
CUEVA VARGAS J L, BELFORTE N, DI POLO A. The glial cell modulator ibudilast attenuates neuroinflammation and enhances retinal ganglion cell viability in glaucoma through protein kinase A signaling[J]. Neurobiol Dis, 2016, 93: 156-171. DOI: 10.1016/j.nbd.2016.05.002.
RIECK J. The pathogenesis of glaucoma in the interplay with the immune system[J]. Invest Ophthalmol Vis Sci, 2013, 54(3): 2393. DOI: 10.1167/iovs.12-9781.
NYSTRÖM S, ANTOINE D J, LUNDBÄCK P, et al . TLR activation regulates damage-associated molecular pattern isoforms released during pyroptosis[J ] . EMBO J, 2013, 32(1): 86-99. DOI: 10.1038/emboj.2012.328.
CHI W, LI F, CHEN H R, et al . Caspase-8 promotes NLRP1/NLRP3 inflammasome activation and IL-1β production in acute glaucoma[J ] . Proc Natl Acad Sci USA, 2014, 111(30): 11181-11186. DOI: 10.1073/pnas.1402819111.
WANG K, PENG B, LIN B. Fractalkine receptor regulates microglial neurotoxicity in an experimental mouse glaucoma model[J]. Glia, 2014, 62(12): 1943-1954. DOI: 10.1002/glia.22715.
JORGENSEN I, ZHANG Y, KRANTZ B A, et al . Pyroptosis triggers pore-induced intracellular traps (PITs) that capture bacteria and lead to their clearance by efferocytosis[J ] . J Exp Med, 2016, 213(10): 2113-2128. DOI: 10.1084/jem.20151613.
GONG T, YANG Y Q, JIN T C, et al . Orchestration of NLRP3 inflammasome activation by ion fluxes[J ] . Trends Immunol, 2018, 39(5): 393-406. DOI: 10.1016/j.it.2018.01.009.
TODD L, PALAZZO I, SUAREZ L, et al . Reactive microglia and IL1β/IL-1R1-signaling mediate neuroprotection in excitotoxin-damaged mouse Retina[J ] . J Neuroinflam, 2019, 16(1): 118. DOI: 10.1186/s12974-019-1505-5.
MCKENZIE B A, MAMIK M K, SAITO L B, et al . Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosis[J ] . Proc Natl Acad Sci USA, 2018, 115(26): E6065-E6074. DOI: 10.1073/pnas.1722041115.
TEZEL G. Molecular regulation of neuroinflammation in glaucoma: current knowledge and the ongoing search for new treatment targets[J]. Prog Retin Eye Res, 2021: 100998. DOI: 10.1016/j.preteyeres.2021.100998.
SHI J J, ZHAO Y, WANG K, et al . Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death[J ] . Nature, 2015, 526(7575): 660-665. DOI: 10.1038/nature15514.
LIU X, ZHANG Z B, RUAN J B, et al . Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores[J ] . Nature, 2016, 535(7610): 153-158. DOI: 10.1038/nature18629.
YE J, ZHANG R N, WU F, et al . Non-apoptotic cell death in malignant tumor cells and natural compounds[J ] . Cancer Lett, 2018, 420: 210-227. DOI: 10.1016/j.canlet.2018.01.061.
DE GASSART A, MARTINON F. Pyroptosis: caspase-11 unlocks the gates of death[J]. Immunity, 2015,43(5): 835-837. DOI: 10.1016/j.immuni.2015.10.024.
POH L, KANG S W, BAIK S H, et al . Evidence that NLRC4 inflammasome mediates apoptotic and pyroptotic microglial death following ischemic stroke[J ] . Brain Behav Immun, 2019, 75: 34-47. DOI: 10.1016/j.bbi.2018.09.001.
SILVERMAN S M, WONG W T. Microglia in the retina: roles in development, maturity, and disease[J]. Annu Rev Vis Sci, 2018, 4: 45-77.
HONG P, GU R N, LI F X, et al . NLRP3 inflammasome as a potential treatment in ischemic stroke concomitant with diabetes[J ] . J Neuroinflam, 2019, 16(1): 121. DOI: 10.1186/s12974-019-1498-0.
ANTTILA J E, WHITAKER K W, WIRES E S, et al . Role of microglia in ischemic focal stroke and recovery: focus on Toll-like receptors[J ] . Prog Neuropsychopharmacol Biol Psychiatry, 2017, 79(Pt A): 3-14. DOI: 10.1016/j.pnpbp.2016.07.003.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621